Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with second generation antipsychotics

Psychiatry Research

Volumn 189, Issue 1, 2011, Pages 21-25

  Vuksan Ćusa, Bjanka ^a   Jakovljević, Miro ^a   Šagud, Marina ^a   Mihaljević Peleš, Alma ^a   Marćinko, Darko ^a   Topić, Radmila ^a   Mihaljević, Sanea ^b   Sertić, Jadranka ^a  

^a KBC Zagreb   (Croatia)

^b General Hospital Tomislav Bardek   (Croatia)

Author keywords

Bipolar disorder; Cardiovascular diseases; Homocysteine; Metabolic syndrome; Schizophrenia

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NEUROLEPTIC AGENT; TRIACYLGLYCEROL;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BIPOLAR DISORDER; BLOOD ANALYSIS; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SCHIZOPHRENIA; SCORING SYSTEM; SEX RATIO; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; FEMALE; FOLLOW-UP STUDIES; HOMOCYSTINE; HUMANS; MALE; METABOLIC DISEASES; MIDDLE AGED; PHLEBOTOMY; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 80051698675     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2010.11.021     Document Type: Article

References (43)

1. Akanji A.O., Ohaeri J.U., Al-Shammri S.A., Fatania H.R. Associations of blood homocysteine concentrations in Arab schizophrenic patients. Clinical Biochemistry 2007, 40(13-14):1026-1031.
2. Applebaum J., Shiron H., Sela B.A., Belmaker R.H., Levine J. Homocysteine levels in newly admitted schizophrenic patients. Psychiatry Research 2004, 38(4):413-416.
3. Assies J., Lok A., Bockting C.L., Weverling G.J., Lieverse R., Visser I. Fatty acids and homocysteine levels in patients with reccurent depression: an explorative pilot study. Prostaglandines, Leukotrienes & Essentials Fatty Acids 2004, 70(4):349-356.
4. Bellia C., Bivona G., Scazzone C., Ciaccio M. Association between homocysteinemia and metabolic syndrome in patients with cardiovascular disease. Journal of Therapeutics and Clinical Risk Management 2007, 3(6):999-1001.
5. Birkenaes A.B., Opjordsmoen S., Brunborg C., Engh J.A., Jonsdottir H., Ringen P.A. The level of cardiovascular risk-factors in bipolar disorder equals that of schizophrenia: a comparative study. Journal of Clinical Psychiatry 2007, 68(6):917-923.
6. Bobes J., Arango C., Aranda P., Carmena R., Garcia-Garcia M., Rejas J. Cardiovascular and metabolic risk in outpatients with schizoaffective disorder treated with antipsychotics: Results from the CLAMORS study. European Psychiatry, 29 October, electronic publication 2010, on behalf of the CLAMORS Study Collaborative Group. 10.1016/j.eurpsy.2010.09.001.
7. Calam R.R., Mansoor I., Blaga J. Homocysteine Stability in Heparinized Plasma Stored in a Gel Separator Tube. Clinical Chemistry 2005, 51(8):1554-1555.
8. Cardenas J., Frye M.A., Marusak S.L., Levander M.E., Chirichigno W.J., Lewis S. Modal subcomponents of metabolic syndrome in patients with bipolar disorder. Journal of Affective Disorders 2008, 106:91-97.
9. Carmel R., Green R., Rosenblatt D.S., Watkins D. Update on cobalamin, folate and homocysteine. American Society of Hematology-Hematol Educ Program 2003, 62-81.
10. Corell C.U., Frederickson A.M., Kane J.M., Manu P. Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics. Bipolar Disorders 2008, 10(7):788-797.
11. Cortese C., Motti C. MTHFR polymorphism, homocysteine and cardiovascular disease. Public Health Nutrition 2001, 4(2B):493-497.
12. Dierkes J., Westphal S. Effect of drugs on homocysteine concentrations. Seminars in Vascular Medicine 2005, 5(2):124-139.
13. Dittman S., Seemuller F., Grunze H.C., Schwarz M.J., Zach J., Fast K. The impact of homocysteine levels on cognition in euthymic bipolar patients: a cross-sectional study. Journal of Clinical Psychiatry 2008, 69(6):899-906.
14. Dittmann S., Seemuller F., Schwarz M.J., Kleidendienst N., Stampfer R., Zach J. Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results. Bipolar Disorders 2007, 9:63-70.
15. Executive Summary The Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Journal of American Medical Association 2001, 285:2486-2497.
16. Fagiollini A., Frank E., Scott J.A., Turkin S., Kupfer D.J. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disorders 2005, 7:424-430.
17. Feng L., Song Z., Xin F., Hu J. Association of plasma homocysteine and methylentetrahydrofolate reductase C677T gene variant with schizophrenia: A Chinese Han population -based case-control study. Psychiatry Research 2009, 168(3):205-208.
18. Garcin J.M., Cremadas S., Garcia-Hejl C., Bordier L., Dupuy O., Mayaudon H. Is hyperhomocysteinemia an additional risk factor of the metabolic syndrome?. Metabolic Syndrome Related Disorders 2006, 4(3):185-195.
19. Gilbody S., Lightfoot T., Sheldon T. Is low folate a risk factor for depression? A meta analysis and exploration of heterogeneity. Journal of Epidemiology and Community Health 2007, 61(7):631-637.
20. Gupta A., Gupta V. Metabolic syndrome: What are the risks for humans?. BioScience Trends 2010, 5(4):204-212.
21. Hamilton M.A. Rating scale for depression. Journal of Neurology, Neurosurgery & Psychiatry 1960, 23:56-62.
22. Hermann W., Lorenzl S., Obeid R. Review of role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric disorders-current evidence and preliminary recommendations. Fortschritte der Neurologie- Psychiatrie 2007, 75(9):515-527.
23. Hirsch S., Ronco A.M., Vasquez M., de la Maza M.P., Garrido A., Barrera G., Gattas V., Glasinovic A., Leiva L., Bunout D. Hyperhomocysteinemia in healthy young men and elderly men with normal serum folate concentration is not associated with poor vascular reactivity or oxidative stress. Journal of Nutrition 2004, 134(7):1832-1835.
24. Kay S.R., Fizbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987, 261.
25. Kilbourne A.M., Brar J.S., Drayer R.A., Xu X., Post E.P. Cardiovascular disease and metabolic risk factors in male patients with schizophrenia, schizoaffective disorder, and bipolar disorder. Psychosomatics 2007, 48:412-417.
26. Levine J., Stahl Z., Sela B.A., Gavendo S., Ruderman V., Belmaker R.H. Elevated homocysteine levels in young male patients with schizophrenia. American Journal of Psychiatry 2002, 159(10):1790-1792.
27. Levine J., Sela B.A., Osher Y., Belmaker R.H. High homocysteine levels in young male schizophrenia and bipolar patients and in an animal model. Progress in Neuropsychopharmacology and Biological Psychiatry 2005, 29(7):1181-1191.
28. Lonn E., Grewal J. Drug therapy in the secondary prevention of cardiovascular diseases: Successes, shortcomings and future directions. Current Vascular Pharmacology 2006, 4(3):253-268.
29. Mangoni A.A., Jackson S.H. Homocysteine and cardiovascular disease: current evidence and future prospects. American Journal of Medicine 2002, 112(7):556-565.
30. Neeman G., Blanaru M., Bloch B., Kremer I., Ermilov M., Javitt D.C., Heresco -Levy U. Relation of plasma glycine, serine, and homocysteine levels to schizophrenia symptoms and medication type. American Journal of Psychiatry 2005, 162(9):1738-1740.
31. Ninomiya J.K., L'Italien G., Criqui M.H., Whyte J.L., Gamst A., Chen R.S. Association of the metabolic syndrome with history of myocardial infarction and stroke in The Third National Health and Nutritional Examination Survey. Circulation 2004, 109:42-46.
32. Obeid R., Herrmann W. Homocysteine and lipids; S-adenosylmethionine as a key intermediate. Clinical Biochemistry 2007, 40(13-14):1026-1031.
33. Osher Y., Sela B.A., Levine J., Belmaker R.H. Elevated homocysteine levels in euthymic bipolar disorder patients showing functional deterioration. Bipolar Disorders 2004, 6(1):82-86.
34. Ozbek Z., Kucukali C.I., Ozkok E., Orhan N., Aydin M., Kilic G. Effect of the methylentetra hydrofolate reductase gene polymorphisms on homocysteine, folate and vitamin B12 in patients with bipolar disorder and relatives. Progress in Neuropsychopharmacology and Biological Psychiatry 2008, 32:1331-1337.
35. Regitz-Zagrosek V., Lehmkul E., Wickert M.O. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clinical Research in Cardiology 2006, 95(3):136-147.
36. Reif A., Pfuhlmann B., Lesch K.P. Homocysteinemia as well as methylentetrahydrofolate reductase polymorphism are associated with affective psychoses. Progress in Neuropsychopharmacology and Biological Psychiatry 2005, 1162-1168.
37. Sarandol A., Kirli S., Akkaya C., Ocak N., Eroz E., Sarandol E. Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment. Journal of Psychopharmacology 2007, 21(8):857-863.
38. Stabler S.P., Marcell P.D., Podell E.R., Allen R. Quantitation of total homocysteine, total cysteine and methionine in normal serum and urine using capillary gas chromatography- mass spectrometry. Analytical Biochemistry 1987, 162:185-196.
39. Stanger O., Fowler B., Piertzik K., Huemer M., Haschke-Becher E., Semmler A. Homocysteine, folate and vitamin B (12) in neuropsychiatric diseases: review and treatment recommendations. Expert Review of Neurotherapeutics 2009, 9(9):1393-1441.
40. To-Figueras J., Lopez R.M., Deulofeu R., Herrero C. Hyperhomocysteinemia in patients with acute intermittent porphyria. Metabolism 2010, 59(12):1809-1810.
41. Vuksan-Ćusa B., Marčinko D., Nad{stroke} S., JakovljeviĆ M. Differences in cholesterol and metabolic syndrome between bipolar disorder men with and without suicide attempts. Progress in Neuropsychopharmacology and Biological Psychiatry 2009, 33(1):109-112.
42. World Health Organization World Health Organization International Statistical Classification of Diseases and Related Health Problems, Tenth Revision 1996, WHO, Geneva.
43. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry 1978, 133:149-435.